Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.7.0.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating expenses:    
Research and development $ 706 $ 567
Research and development - licenses acquired 575 0
General and administrative 2,025 255
Loss from operations (3,306) (822)
Other income (expense)    
Interest income 90 0
Interest expense - related party (2) (81)
Total other income (expense) 88 (81)
Net Loss $ (3,218) $ (903)
Net loss per common share outstanding, basic and diluted $ (0.14) $ (0.09)
Weighted average number of common shares outstanding, basic and diluted 22,401,000 10,052,198